Gavekal Technologies

Alibaba promotes token plans via livestream e-commerce. Do the US midterms spell the end of the datacenter boom? China debates the social value of “ByteDance Time”.

China’s two “Wuxi” biotech firms—AppTec and Biologics—are key partners for the US pharmaceutical industry, as contract developers and manufacturers of hundreds of thousands of chemical compounds. Washington lawmakers are increasingly uneasy about rising American reliance on the Wuxi firms. But their efforts to curb Wuxi’s access to the US market have been blocked, thanks to strong lobbying by the US pharma and biotech industries.